32,708 Shares in BlackRock Health Sciences Term Trust (NYSE:BMEZ) Bought by C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 32,708 shares of the company’s stock, valued at approximately $471,000.

Other institutional investors have also added to or reduced their stakes in the company. Oppenheimer & Co. Inc. grew its holdings in shares of BlackRock Health Sciences Term Trust by 0.6% during the third quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock worth $3,237,000 after purchasing an additional 1,153 shares in the last quarter. Brown Brothers Harriman & Co. bought a new stake in BlackRock Health Sciences Term Trust during the third quarter valued at approximately $32,000. Brown Lisle Cummings Inc. increased its holdings in shares of BlackRock Health Sciences Term Trust by 6.2% in the 3rd quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock worth $578,000 after buying an additional 2,128 shares during the last quarter. Dakota Wealth Management raised its position in shares of BlackRock Health Sciences Term Trust by 23.4% during the 3rd quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after buying an additional 4,267 shares in the last quarter. Finally, Stifel Financial Corp raised its position in shares of BlackRock Health Sciences Term Trust by 2.2% during the 3rd quarter. Stifel Financial Corp now owns 414,346 shares of the company’s stock valued at $6,563,000 after buying an additional 8,843 shares in the last quarter.

BlackRock Health Sciences Term Trust Trading Up 0.1 %

Shares of NYSE:BMEZ opened at $16.05 on Friday. BlackRock Health Sciences Term Trust has a 52-week low of $14.27 and a 52-week high of $16.75. The firm has a fifty day moving average of $15.55 and a 200 day moving average of $15.67.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Friday, February 28th. Stockholders of record on Friday, February 14th will be issued a $0.1773 dividend. This represents a $2.13 dividend on an annualized basis and a dividend yield of 13.26%. The ex-dividend date is Friday, February 14th.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.